Diabetes Care (ISSN 0149-5992) is a prestigious peer-reviewed journal published by the American Diabetes Association in the United States, serving as a leading platform for high-impact research in the field of diabetes. As a monthly publication indexed in the Science Citation Index (SCI), it consistently maintains a high impact factor and is typically ranked in the first or second quartile of the Chinese Academy of Sciences (CAS) medical journal categories, reflecting its significant standing within the global academic community. The journal focuses on a broad spectrum of topics, including the clinical management, epidemiology, pathophysiology, and prevention of Type 1, Type 2, and gestational diabetes, as well as associated complications. While not fully open access, Diabetes Care offers optional open access publication for selected articles. Known for its rigorous peer-review process and emphasis on methodological rigor, clinical relevance, and scientific innovation, the journal attracts a competitive pool of submissions and is highly selective, resulting in a relatively high rejection rate. Consequently, Diabetes Care is widely regarded as an authoritative source for original research and comprehensive reviews, making it an ideal venue for researchers seeking to disseminate high-quality findings to a global audience of clinicians, scientists, and healthcare professionals dedicated to improving diabetes care.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com